MEFENAMIC ACID

MEFENAMIC ACID was reported 2221 times

MEFENAMIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CITRIC ACID URINE INCREASED 3 0.5000
1 BROAD LIGAMENT TEAR 3 0.3750
2 GRANULOCYTE PERCENTAGE 3 0.2308
3 INFUSION SITE COLDNESS 22 0.2200
4 VASCULAR MALFORMATION 45 0.2143
5 CEREBELLAR HAEMANGIOMA 5 0.2083
6 PARANASAL CYST 45 0.1852
7 GAMMA-GLUTAMYLTRANSFERASE DECREASED 22 0.1146
8 FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0968
9 ORAL LICHENOID REACTION 7 0.0642
10 ECTRODACTYLY 4 0.0615
11 DEHYDROEPIANDROSTERONE DECREASED 6 0.0606
12 PERIORBITAL DERMATITIS 4 0.0513
13 MASTOIDITIS 46 0.0469
14 CERULOPLASMIN DECREASED 2 0.0465
15 URINE OSMOLARITY INCREASED 7 0.0452
16 URINOMA 7 0.0443
17 ARTERIAL FIBROSIS 2 0.0426
18 NSAID EXACERBATED RESPIRATORY DISEASE 15 0.0397
19 BLOOD PRESSURE ORTHOSTATIC ABNORMAL 6 0.0387
20 RABBIT SYNDROME 6 0.0361
21 AORTIC BRUIT 3 0.0312
22 RENAL PAPILLARY NECROSIS 6 0.0279
23 POST-TRAUMATIC NECK SYNDROME 22 0.0272
24 MONONEUROPATHY MULTIPLEX 10 0.0216
25 DENTAL FISTULA 9 0.0216
26 ALLERGIC RESPIRATORY DISEASE 3 0.0216
27 CILIARY HYPERAEMIA 2 0.0211
28 GASTROENTERITIS RADIATION 6 0.0182
29 DACTYLITIS 17 0.0173
30 ENTHESOPATHY 27 0.0173
31 ANAL ERYTHEMA 2 0.0160
32 INFUSION SITE INDURATION 22 0.0148
33 MEAN CELL HAEMOGLOBIN DECREASED 27 0.0147
34 ANHIDROSIS 6 0.0147
35 OTITIS MEDIA 48 0.0145
36 JOINT ANKYLOSIS 8 0.0141
37 LID SULCUS DEEPENED 5 0.0134
38 BODY DYSMORPHIC DISORDER 5 0.0133
39 PLEURAL INFECTION 3 0.0129
40 RENAL ISCHAEMIA 7 0.0128
41 URINARY SEDIMENT PRESENT 8 0.0124
42 BLOOD CORTICOTROPHIN DECREASED 6 0.0123
43 SYNOVIAL DISORDER 5 0.0110
44 SOFT TISSUE DISORDER 12 0.0108
45 CRYSTAL URINE PRESENT 6 0.0108
46 BRAIN STEM SYNDROME 8 0.0107
47 TRICHOTILLOMANIA 6 0.0102
48 ALOPECIA UNIVERSALIS 3 0.0102
49 CRYSTAL NEPHROPATHY 6 0.0101
50 BACTERIAL TEST 3 0.0101
51 HEAT STROKE 15 0.0099
52 BLADDER PROLAPSE 12 0.0098
53 EXPOSURE TO COMMUNICABLE DISEASE 7 0.0093
54 ALOPECIA TOTALIS 3 0.0091
55 VASODILATATION 23 0.0091
56 RECTAL PROLAPSE 11 0.0091
57 VANISHING BILE DUCT SYNDROME 10 0.0090
58 NON-ALCOHOLIC FATTY LIVER 3 0.0089
59 SKIN SENSITISATION 9 0.0087
60 SCAN ABNORMAL 3 0.0081
61 DEEP VEIN THROMBOSIS POSTOPERATIVE 16 0.0080
62 URINARY CASTS 3 0.0077
63 SOCIAL ANXIETY DISORDER 5 0.0076
64 THEFT 5 0.0075
65 GRANULOCYTE COUNT INCREASED 3 0.0074
66 THERAPY REGIMEN CHANGED 3 0.0074
67 INFLAMMATORY MARKER INCREASED 35 0.0071
68 NEPHROGENIC DIABETES INSIPIDUS 8 0.0069
69 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 14 0.0068
70 INFUSION SITE HAEMORRHAGE 22 0.0067
71 BACTERIAL VAGINOSIS 10 0.0064
72 ALLERGIC OEDEMA 4 0.0062
73 GENITAL ERYTHEMA 3 0.0060
74 ACUTE HEPATITIS B 2 0.0060
75 HYPOHIDROSIS 3 0.0060
76 FRACTURED COCCYX 7 0.0055
77 VASOSPASM 5 0.0054
78 BLOOD CREATININE DECREASED 17 0.0054
79 CORTISOL DECREASED 6 0.0052
80 MENOPAUSAL SYMPTOMS 12 0.0052
81 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 4 0.0051
82 LYMPHOCYTE STIMULATION TEST POSITIVE 4 0.0050
83 ILEAL ULCER 5 0.0049
84 POST HERPETIC NEURALGIA 7 0.0049
85 BLOOD PRESSURE SYSTOLIC ABNORMAL 12 0.0049
86 VEIN DISORDER 24 0.0048
87 HAEMANGIOMA 11 0.0048
88 PERIORAL DERMATITIS 3 0.0047
89 BLOOD PRESSURE DIASTOLIC ABNORMAL 12 0.0047
90 NODULAR REGENERATIVE HYPERPLASIA 3 0.0047
91 ENTEROCOCCUS TEST POSITIVE 3 0.0046
92 SOMATIC SYMPTOM DISORDER 5 0.0046
93 INFUSION SITE MASS 5 0.0046
94 THERAPEUTIC PRODUCT CROSS-REACTIVITY 4 0.0045
95 FALSE NEGATIVE INVESTIGATION RESULT 3 0.0043
96 MONOCYTE PERCENTAGE INCREASED 3 0.0042
97 HYPOREFLEXIA 8 0.0042
98 CROSS SENSITIVITY REACTION 4 0.0041
99 EPIDERMAL NECROSIS 4 0.0041
100 DARK CIRCLES UNDER EYES 6 0.0041
101 FIXED ERUPTION 7 0.0041
102 SPINAL PAIN 44 0.0038
103 WHITE BLOOD CELLS URINE POSITIVE 7 0.0037
104 SACROILIITIS 7 0.0037
105 LEUKOCYTURIA 3 0.0036
106 HYPOGEUSIA 7 0.0036
107 FOOD AVERSION 6 0.0035
108 CATAPLEXY 5 0.0035
109 TENSION HEADACHE 15 0.0035
110 VITAMIN B12 DECREASED 10 0.0035
111 JUDGEMENT IMPAIRED 5 0.0034
112 PERIPHERAL NERVE INJURY 3 0.0034
113 ADENOMYOSIS 2 0.0034
114 IRRITABLE BOWEL SYNDROME 72 0.0034
115 PROTEIN URINE 3 0.0033
116 STEM CELL TRANSPLANT 8 0.0032
117 BIPOLAR I DISORDER 7 0.0032
118 STEREOTYPY 3 0.0032
119 NEUTROPHIL PERCENTAGE INCREASED 4 0.0032
120 HYPERMETROPIA 3 0.0032
121 FACIAL PARESIS 11 0.0031
122 RED BLOOD CELLS URINE POSITIVE 3 0.0031
123 TONIC CLONIC MOVEMENTS 4 0.0031
124 DISLOCATION OF VERTEBRA 7 0.0031
125 ANKYLOSING SPONDYLITIS 40 0.0030
126 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
127 ARTERIOSPASM CORONARY 12 0.0030
128 LYMPHOCYTE PERCENTAGE DECREASED 4 0.0030
129 AUTOIMMUNE DISORDER 29 0.0030
130 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
131 CENTRAL SEROUS CHORIORETINOPATHY 2 0.0029
132 MAST CELL ACTIVATION SYNDROME 4 0.0028
133 ACUTE PSYCHOSIS 7 0.0028
134 C-REACTIVE PROTEIN ABNORMAL 18 0.0028
135 X-RAY ABNORMAL 5 0.0028
136 STRESS URINARY INCONTINENCE 3 0.0028
137 KIDNEY ENLARGEMENT 3 0.0028
138 HYPERSEXUALITY 5 0.0027
139 COMA HEPATIC 2 0.0027
140 URINE OUTPUT INCREASED 7 0.0027
141 KLEBSIELLA SEPSIS 3 0.0027
142 BODY TEMPERATURE DECREASED 26 0.0026
143 INJECTION SITE PARAESTHESIA 4 0.0026
144 ACUTE PRERENAL FAILURE 3 0.0026
145 MUCOSAL HAEMORRHAGE 3 0.0026
146 INCONTINENCE 27 0.0026
147 EROSIVE DUODENITIS 2 0.0025
148 CHOROIDAL EFFUSION 2 0.0025
149 BREAST CANCER STAGE III 16 0.0025
150 FACET JOINT SYNDROME 8 0.0025
151 TENDON DISORDER 16 0.0025
152 ORAL MUCOSA EROSION 3 0.0024
153 IMPULSE-CONTROL DISORDER 5 0.0024
154 PRE-EXISTING CONDITION IMPROVED 15 0.0024
155 RETINAL DETACHMENT 22 0.0024
156 BAND SENSATION 3 0.0024
157 MENOPAUSE 6 0.0023
158 INFUSION SITE BRUISING 5 0.0023
159 ADJUSTMENT DISORDER 3 0.0023
160 POLYARTHRITIS 12 0.0023
161 SYNOVITIS 40 0.0022
162 INJECTION SITE INFLAMMATION 11 0.0022
163 CHRONIC FATIGUE SYNDROME 3 0.0022
164 POOR VENOUS ACCESS 22 0.0021
165 CONGENITAL ANOMALY 16 0.0021
166 JUVENILE IDIOPATHIC ARTHRITIS 5 0.0020
167 PERIPHERAL COLDNESS 28 0.0020
168 ENTEROCOLITIS HAEMORRHAGIC 3 0.0020
169 GASTRITIS HAEMORRHAGIC 3 0.0020
170 INFREQUENT BOWEL MOVEMENTS 5 0.0020
171 SENSORY LOSS 16 0.0020
172 BONE EROSION 7 0.0020
173 GLOSSITIS 7 0.0020
174 PERIPHERAL VENOUS DISEASE 8 0.0020
175 ORAL MUCOSAL ERYTHEMA 3 0.0019
176 BONE MARROW OEDEMA 2 0.0019
177 GRIP STRENGTH DECREASED 17 0.0019
178 URINE KETONE BODY PRESENT 3 0.0019
179 NEONATAL DISORDER 3 0.0019
180 TONGUE DISCOMFORT 8 0.0019
181 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
182 MULTIPLE DRUG OVERDOSE INTENTIONAL 6 0.0019
183 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
184 THERMAL BURN 13 0.0018
185 PLEURITIC PAIN 5 0.0018
186 BACTERIAL TEST POSITIVE 4 0.0018
187 LUNG CONSOLIDATION 5 0.0018
188 VITAMIN D DECREASED 15 0.0018
189 ARTHROPOD BITE 13 0.0018
190 DEPRESSION SUICIDAL 6 0.0017
191 HYPOPNOEA 6 0.0017
192 PEMPHIGOID 13 0.0017
193 URINE ODOUR ABNORMAL 10 0.0017
194 HEPATITIS FULMINANT 5 0.0017
195 ENDOMETRIOSIS 8 0.0017
196 URINE ANALYSIS ABNORMAL 5 0.0017
197 HYPOVOLAEMIC SHOCK 8 0.0017
198 GASTROINTESTINAL INFLAMMATION 13 0.0017
199 EXOSTOSIS 15 0.0016
200 HORMONE LEVEL ABNORMAL 8 0.0016
201 BRONCHITIS CHRONIC 4 0.0016
202 MYDRIASIS 21 0.0016
203 BLOOD PRESSURE DIASTOLIC DECREASED 12 0.0016
204 DUODENAL ULCER PERFORATION 12 0.0016
205 IMMUNODEFICIENCY 24 0.0016
206 FEELING COLD 44 0.0016
207 NON-CARDIAC CHEST PAIN 5 0.0016
208 RHEUMATIC FEVER 7 0.0016
209 ANGLE CLOSURE GLAUCOMA 4 0.0016
210 ASPERGILLOSIS 2 0.0015
211 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
212 DRUG INTOLERANCE 146 0.0015
213 YELLOW SKIN 7 0.0015
214 UVEITIS 20 0.0015
215 MUSCULOSKELETAL DISORDER 28 0.0015
216 OLIGURIA 9 0.0014
217 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69 0.0014
218 TOOTHACHE 26 0.0014
219 TYPE I HYPERSENSITIVITY 5 0.0014
220 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
221 METASTASES TO BONE 23 0.0014
222 DUODENAL ULCER HAEMORRHAGE 4 0.0014
223 FACIAL PALSY 3 0.0014
224 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
225 ESCHERICHIA SEPSIS 4 0.0014
226 IMMOBILE 6 0.0014
227 BLOOD POTASSIUM INCREASED 22 0.0014
228 PERIORBITAL OEDEMA 7 0.0013
229 TUBULOINTERSTITIAL NEPHRITIS 25 0.0013
230 PSORIATIC ARTHROPATHY 54 0.0013
231 EOSINOPHIL COUNT INCREASED 11 0.0013
232 TOXIC EPIDERMAL NECROLYSIS 20 0.0013
233 HAEMATOCRIT INCREASED 3 0.0013
234 IRITIS 4 0.0013
235 ENCEPHALITIS 9 0.0013
236 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
237 ORAL DISCOMFORT 18 0.0013
238 PHOTOSENSITIVITY REACTION 21 0.0013
239 STEVENS-JOHNSON SYNDROME 28 0.0013
240 HYPERPHAGIA 5 0.0013
241 CYSTITIS INTERSTITIAL 2 0.0012
242 ANGIOEDEMA 55 0.0012
243 FIBROMYALGIA 30 0.0012
244 COSTOCHONDRITIS 2 0.0012
245 ORAL DISORDER 9 0.0012
246 INFLAMMATORY BOWEL DISEASE 12 0.0012
247 RHEUMATOID FACTOR POSITIVE 7 0.0012
248 SKIN INJURY 4 0.0012
249 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
250 TACHYARRHYTHMIA 3 0.0012
251 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
252 DRUG TOLERANCE 6 0.0012
253 HOSTILITY 3 0.0012
254 DISCOMFORT 72 0.0012
255 SUBARACHNOID HAEMORRHAGE 12 0.0012
256 DISTURBANCE IN ATTENTION 63 0.0012
257 BLOOD CHLORIDE INCREASED 2 0.0012
258 DYSPHEMIA 5 0.0011
259 GASTRITIS 30 0.0011
260 VULVOVAGINAL DISCOMFORT 5 0.0011
261 RHINITIS ALLERGIC 5 0.0011
262 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
263 MIOSIS 9 0.0011
264 EAR CONGESTION 3 0.0011
265 LARGE INTESTINAL ULCER 3 0.0011
266 MIGRAINE WITH AURA 3 0.0011
267 URINE ABNORMALITY 5 0.0011
268 UTERINE LEIOMYOMA 8 0.0011
269 MUSCULOSKELETAL STIFFNESS 95 0.0011
270 ALCOHOL USE 4 0.0011
271 RHEUMATOID ARTHRITIS 123 0.0011
272 DENTAL CARE 2 0.0011
273 C-REACTIVE PROTEIN INCREASED 39 0.0011
274 UMBILICAL HERNIA 5 0.0011
275 IMPAIRED DRIVING ABILITY 12 0.0011
276 THERAPEUTIC RESPONSE DECREASED 64 0.0011
277 HEPATITIS 27 0.0011
278 TENDON RUPTURE 13 0.0011
279 SLEEP APNOEA SYNDROME 20 0.0010
280 SUBCUTANEOUS ABSCESS 5 0.0010
281 MOUTH SWELLING 6 0.0010
282 OESOPHAGEAL DISORDER 4 0.0010
283 IMPAIRED HEALING 34 0.0010
284 PAIN IN JAW 29 0.0010
285 NEUTROPHIL COUNT DECREASED 41 0.0010
286 ODYNOPHAGIA 6 0.0010
287 SKIN PAPILLOMA 4 0.0010
288 CORONARY ARTERY THROMBOSIS 2 0.0010
289 CRANIOCEREBRAL INJURY 3 0.0010
290 DIVERTICULUM 7 0.0010
291 NEUTROPHIL COUNT INCREASED 10 0.0010
292 PIGMENTATION DISORDER 6 0.0010
293 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
294 THERAPY PARTIAL RESPONDER 15 0.0010
295 THROAT TIGHTNESS 26 0.0010
296 ABORTION INDUCED 9 0.0010
297 EOSINOPHILIC PNEUMONIA 3 0.0010
298 INFLAMMATION 49 0.0009
299 BLADDER PAIN 3 0.0009
300 PHARYNGOLARYNGEAL PAIN 5 0.0009
301 STUPOR 3 0.0009
302 COMPRESSION FRACTURE 5 0.0009
303 SINUS BRADYCARDIA 9 0.0009
304 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
305 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 6 0.0009
306 CHAPPED LIPS 4 0.0009
307 MONOPLEGIA 4 0.0009
308 RENAL FAILURE ACUTE 39 0.0009
309 OEDEMA MOUTH 3 0.0009
310 HEPATIC FUNCTION ABNORMAL 34 0.0009
311 ASTHENOPIA 5 0.0009
312 GINGIVAL SWELLING 4 0.0009
313 POTENTIATING DRUG INTERACTION 3 0.0009
314 PERIORBITAL SWELLING 5 0.0009
315 ABNORMAL LOSS OF WEIGHT 6 0.0009
316 MICTURITION URGENCY 10 0.0009
317 EAR PAIN 17 0.0009
318 EAR DISORDER 4 0.0009
319 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
320 APHTHOUS STOMATITIS 2 0.0009
321 DELIRIUM 30 0.0009
322 MIGRAINE 82 0.0009
323 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61 0.0009
324 GASTRIC ULCER 16 0.0008
325 CONJUNCTIVAL HYPERAEMIA 3 0.0008
326 ARTHRITIS 66 0.0008
327 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6 0.0008
328 DIABETES INSIPIDUS 2 0.0008
329 BREATH ODOUR 2 0.0008
330 JOINT RANGE OF MOTION DECREASED 11 0.0008
331 HYPOMANIA 3 0.0008
332 SCIATICA 13 0.0008
333 BLOOD CHOLESTEROL INCREASED 38 0.0008
334 NASAL POLYPS 4 0.0008
335 SPINAL OPERATION 10 0.0008
336 TOOTH DISORDER 18 0.0008
337 PYELONEPHRITIS 7 0.0008
338 NECK PAIN 45 0.0008
339 HAEMORRHAGE INTRACRANIAL 12 0.0008
340 PROTEIN URINE PRESENT 4 0.0008
341 SEDATION 21 0.0008
342 SWELLING 75 0.0008
343 NASAL DRYNESS 5 0.0008
344 SPINAL OSTEOARTHRITIS 7 0.0008
345 CORONARY ARTERY STENOSIS 4 0.0008
346 INFUSION SITE SWELLING 5 0.0008
347 INTENTIONAL SELF-INJURY 16 0.0008
348 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
349 THERAPEUTIC PRODUCT EFFECT DECREASED 35 0.0008
350 HEAVY MENSTRUAL BLEEDING 7 0.0008
351 INFUSION SITE PAIN 10 0.0008
352 APHTHOUS ULCER 6 0.0008
353 FOETAL DEATH 4 0.0008
354 FACE OEDEMA 13 0.0008
355 LIP DRY 7 0.0008
356 TONSILLITIS 4 0.0008
357 INCREASED TENDENCY TO BRUISE 7 0.0008
358 DRUG SCREEN POSITIVE 6 0.0008
359 BLOOD ALBUMIN DECREASED 6 0.0008
360 RENAL PAIN 8 0.0008
361 OESOPHAGEAL CANDIDIASIS 3 0.0008
362 HEPATIC STEATOSIS 14 0.0008
363 ANGIONEUROTIC OEDEMA 2 0.0007
364 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
365 ANAL FISSURE 4 0.0007
366 BURSITIS 9 0.0007
367 ROAD TRAFFIC ACCIDENT 31 0.0007
368 PERIPHERAL SWELLING 114 0.0007
369 CHEILITIS 4 0.0007
370 PHARYNGITIS STREPTOCOCCAL 8 0.0007
371 SPINAL DISORDER 7 0.0007
372 LYMPHOCYTE COUNT DECREASED 13 0.0007
373 GOITRE 3 0.0007
374 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
375 SELF-MEDICATION 3 0.0007
376 JOINT SWELLING 88 0.0007
377 FOOT DEFORMITY 8 0.0007
378 ORAL HERPES 14 0.0007
379 DERMATITIS ALLERGIC 9 0.0007
380 PERICARDITIS 12 0.0007
381 RENAL TUBULAR NECROSIS 7 0.0007
382 MUSCULOSKELETAL PAIN 37 0.0007
383 UTERINE HAEMORRHAGE 3 0.0007
384 PULMONARY TUBERCULOSIS 3 0.0007
385 NEURALGIA 17 0.0007
386 ANURIA 6 0.0007
387 PARAESTHESIA ORAL 10 0.0007
388 VISUAL FIELD DEFECT 5 0.0007
389 VAGINAL DISCHARGE 7 0.0007
390 OROPHARYNGEAL PAIN 64 0.0007
391 PHOTOPHOBIA 13 0.0007
392 COMA SCALE ABNORMAL 2 0.0007
393 EPILEPSY 21 0.0007
394 JOINT STIFFNESS 18 0.0007
395 BONE PAIN 40 0.0007
396 EAR DISCOMFORT 7 0.0007
397 HELICOBACTER INFECTION 7 0.0007
398 RASH MACULO-PAPULAR 15 0.0007
399 MENINGITIS ASEPTIC 3 0.0007
400 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
401 ANGINA PECTORIS 19 0.0007
402 PALLOR 18 0.0007
403 GINGIVAL BLEEDING 9 0.0007
404 HAEMOGLOBIN INCREASED 3 0.0007
405 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
406 FOOD ALLERGY 5 0.0006
407 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
408 MUSCULOSKELETAL CHEST PAIN 10 0.0006
409 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
410 HEPATIC CIRRHOSIS 12 0.0006
411 DRUG-INDUCED LIVER INJURY 20 0.0006
412 SEASONAL ALLERGY 9 0.0006
413 FAECAL CALPROTECTIN INCREASED 2 0.0006
414 NERVE INJURY 7 0.0006
415 BLOOD PRESSURE FLUCTUATION 15 0.0006
416 FAECAL INCONTINENCE 3 0.0006
417 CARDIAC FLUTTER 4 0.0006
418 HIATUS HERNIA 8 0.0006
419 ASCITES 18 0.0006
420 MULTIPLE DRUG OVERDOSE 3 0.0006
421 MUSCLE INJURY 5 0.0006
422 EAR INFECTION 16 0.0006
423 VASCULITIS 7 0.0006
424 HYPOAESTHESIA ORAL 9 0.0006
425 POST-TRAUMATIC STRESS DISORDER 4 0.0006
426 HAEMODIALYSIS 5 0.0006
427 INFUSION SITE ERYTHEMA 5 0.0006
428 URTICARIA 99 0.0006
429 NIGHT SWEATS 19 0.0006
430 LIMB INJURY 16 0.0006
431 NEPHROLITHIASIS 27 0.0006
432 NIGHTMARE 20 0.0006
433 CATATONIA 3 0.0006
434 MOUTH ULCERATION 12 0.0006
435 ABNORMAL WEIGHT GAIN 7 0.0006
436 NYSTAGMUS 3 0.0006
437 OBESITY 9 0.0006
438 INTENTIONAL OVERDOSE 36 0.0006
439 BRUXISM 3 0.0006
440 ANAL INCONTINENCE 5 0.0006
441 DERMATITIS BULLOUS 4 0.0006
442 MAJOR DEPRESSION 4 0.0005
443 DYSURIA 20 0.0005
444 ANOREXIA 7 0.0005
445 MOBILITY DECREASED 39 0.0005
446 MENTAL STATUS CHANGES 15 0.0005
447 ARTHROPATHY 30 0.0005
448 CONJUNCTIVITIS 10 0.0005
449 FEELING HOT 33 0.0005
450 PERSONALITY CHANGE 5 0.0005
451 PLATELET COUNT INCREASED 7 0.0005
452 ERYTHEMA MULTIFORME 5 0.0005
453 DYSMENORRHOEA 7 0.0005
454 FACE INJURY 2 0.0005
455 BLOOD PRESSURE DECREASED 35 0.0005
456 RHINORRHOEA 34 0.0005
457 HYPERTONIA 3 0.0005
458 MUSCULOSKELETAL DISCOMFORT 9 0.0005
459 BOWEL MOVEMENT IRREGULARITY 4 0.0005
460 CHILLS 61 0.0005
461 TENDONITIS 8 0.0005
462 DYSTONIA 10 0.0005
463 PARAESTHESIA 81 0.0005
464 INJECTION SITE MASS 19 0.0005
465 EPIGASTRIC DISCOMFORT 2 0.0005
466 LABORATORY TEST ABNORMAL 15 0.0005
467 PLEURISY 3 0.0005
468 ALANINE AMINOTRANSFERASE INCREASED 31 0.0005
469 COORDINATION ABNORMAL 7 0.0005
470 AZOTAEMIA 2 0.0005
471 TREMOR 83 0.0005
472 MYALGIA 85 0.0005
473 WHITE BLOOD CELL COUNT DECREASED 54 0.0005
474 HEPATITIS CHOLESTATIC 3 0.0005
475 ENURESIS 2 0.0005
476 SUICIDE ATTEMPT 30 0.0005
477 HEPATOCELLULAR INJURY 7 0.0005
478 SINUS TACHYCARDIA 7 0.0005
479 TASTE DISORDER 10 0.0005
480 ABDOMINAL PAIN UPPER 101 0.0005
481 RESPIRATORY DEPRESSION 6 0.0005
482 LIVER INJURY 12 0.0005
483 ENCEPHALOPATHY 12 0.0005
484 HEART RATE IRREGULAR 11 0.0005
485 ANAPHYLACTOID REACTION 2 0.0005
486 HEART RATE DECREASED 17 0.0005
487 MENSTRUAL DISORDER 4 0.0005
488 ABDOMINAL DISCOMFORT 81 0.0005
489 TREATMENT FAILURE 40 0.0005
490 PAIN IN EXTREMITY 142 0.0005
491 EYE DISCHARGE 5 0.0005
492 FUNGAL INFECTION 16 0.0005
493 TENDERNESS 5 0.0005
494 LIVE BIRTH 4 0.0005
495 WEIGHT FLUCTUATION 5 0.0005
496 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
497 MUSCLE ATROPHY 6 0.0005
498 HYPOTENSION 95 0.0005
499 COLITIS ULCERATIVE 21 0.0005
500 SEROTONIN SYNDROME 9 0.0005
501 SINUSITIS 48 0.0005
502 ANAPHYLACTIC SHOCK 12 0.0005
503 HYSTERECTOMY 4 0.0005
504 INFLUENZA LIKE ILLNESS 38 0.0005
505 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
506 BLOOD CREATININE INCREASED 30 0.0005
507 MENORRHAGIA 9 0.0005
508 URINE OUTPUT DECREASED 4 0.0005
509 DRUG ERUPTION 8 0.0005
510 CATHETERISATION CARDIAC 2 0.0005
511 CARDIAC FAILURE ACUTE 3 0.0004
512 HYPERTENSIVE CRISIS 5 0.0004
513 HEPATOTOXICITY 10 0.0004
514 OSTEOARTHRITIS 19 0.0004
515 BRONCHITIS 33 0.0004
516 PANCREATITIS ACUTE 10 0.0004
517 EYE INFECTION 5 0.0004
518 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
519 CHOLECYSTECTOMY 5 0.0004
520 NEPHROTIC SYNDROME 3 0.0004
521 RESTLESSNESS 16 0.0004
522 MOVEMENT DISORDER 14 0.0004
523 GASTRIC HAEMORRHAGE 5 0.0004
524 HAEMATEMESIS 11 0.0004
525 DEFAECATION URGENCY 3 0.0004
526 PAPULE 3 0.0004
527 EYE DISORDER 14 0.0004
528 DRUG LEVEL INCREASED 7 0.0004
529 DRUG INTERACTION 67 0.0004
530 URINARY RETENTION 14 0.0004
531 BLOOD UREA INCREASED 7 0.0004
532 LOWER LIMB FRACTURE 8 0.0004
533 ANAPHYLACTIC REACTION 23 0.0004
534 CONTUSION 40 0.0004
535 SKIN DISCOLOURATION 19 0.0004
536 FINGER DEFORMITY 2 0.0004
537 NAUSEA 326 0.0004
538 MALAISE 179 0.0004
539 HEPATOMEGALY 4 0.0004
540 MATERNAL EXPOSURE DURING PREGNANCY 36 0.0004
541 DISORIENTATION 16 0.0004
542 PHARYNGITIS 5 0.0004
543 ABDOMINAL TENDERNESS 2 0.0004
544 LACTIC ACIDOSIS 13 0.0004
545 INJECTION SITE BRUISING 32 0.0004
546 SPEECH DISORDER 21 0.0004
547 BONE LOSS 6 0.0004
548 POISONING 5 0.0004
549 BRAIN OEDEMA 5 0.0004
550 DIZZINESS 196 0.0004
551 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
552 EJECTION FRACTION DECREASED 6 0.0004
553 LIVER DISORDER 17 0.0004
554 PETECHIAE 4 0.0004
555 FOLLICULITIS 4 0.0004
556 HEADACHE 239 0.0004
557 HYPOAESTHESIA 57 0.0004
558 BLOOD LACTIC ACID INCREASED 2 0.0004
559 IMMUNE SYSTEM DISORDER 5 0.0004
560 BACK PAIN 88 0.0004
561 OEDEMA PERIPHERAL 46 0.0004
562 ARTHRALGIA 156 0.0004
563 NASOPHARYNGITIS 69 0.0004
564 IMPAIRED WORK ABILITY 8 0.0004
565 RHINITIS 3 0.0004
566 TACHYCARDIA 33 0.0004
567 BLOOD URINE PRESENT 7 0.0004
568 DECUBITUS ULCER 3 0.0004
569 DRUG TOXICITY 5 0.0004
570 POLYURIA 3 0.0004
571 HICCUPS 3 0.0004
572 WOUND INFECTION 4 0.0004
573 GASTROINTESTINAL PAIN 4 0.0004
574 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
575 PRESCRIBED OVERDOSE 7 0.0004
576 CHEST PAIN 67 0.0004
577 EMBOLISM 3 0.0004
578 DECREASED APPETITE 83 0.0004
579 ACUTE PULMONARY OEDEMA 2 0.0004
580 CHROMATURIA 8 0.0004
581 LYMPHOPENIA 5 0.0004
582 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
583 HAEMATOCRIT DECREASED 7 0.0004
584 CHOLECYSTITIS ACUTE 2 0.0004
585 METRORRHAGIA 6 0.0004
586 SCAR 6 0.0004
587 CONVULSION 20 0.0003
588 HYPERHIDROSIS 45 0.0003
589 RECTAL HAEMORRHAGE 15 0.0003
590 UNRESPONSIVE TO STIMULI 9 0.0003
591 SHOCK 8 0.0003
592 ACCIDENTAL UNDERDOSE 5 0.0003
593 MYOPATHY 3 0.0003
594 PLATELET COUNT DECREASED 37 0.0003
595 MUCOSAL INFLAMMATION 9 0.0003
596 FLUID OVERLOAD 5 0.0003
597 FATIGUE 265 0.0003
598 PAIN 209 0.0003
599 IMMUNOSUPPRESSION 3 0.0003
600 PANCYTOPENIA 19 0.0003
601 DECREASED INTEREST 2 0.0003
602 HEAD DISCOMFORT 6 0.0003
603 MUSCLE SPASMS 62 0.0003
604 URINARY INCONTINENCE 10 0.0003
605 RHABDOMYOLYSIS 14 0.0003
606 MYOCLONUS 4 0.0003
607 POLYNEUROPATHY 4 0.0003
608 DRY MOUTH 27 0.0003
609 PYREXIA 115 0.0003
610 ALOPECIA 65 0.0003
611 RESTLESS LEGS SYNDROME 6 0.0003
612 SUICIDAL IDEATION 30 0.0003
613 TINNITUS 15 0.0003
614 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
615 DRUG ABUSER 2 0.0003
616 ANKLE FRACTURE 5 0.0003
617 INFLUENZA 36 0.0003
618 EXTRAPYRAMIDAL DISORDER 8 0.0003
619 TOOTH EXTRACTION 4 0.0003
620 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
621 SPUTUM DISCOLOURED 3 0.0003
622 OSTEOPOROSIS 13 0.0003
623 HEAD INJURY 10 0.0003
624 FLUSHING 32 0.0003
625 GASTROINTESTINAL DISORDER 28 0.0003
626 ENTERITIS 2 0.0003
627 CHOLESTASIS 6 0.0003
628 RASH PAPULAR 7 0.0003
629 HYPERCHOLESTEROLAEMIA 3 0.0003
630 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
631 DIZZINESS POSTURAL 3 0.0003
632 ANXIETY 88 0.0003
633 AMNESIA 20 0.0003
634 NASAL CONGESTION 18 0.0003
635 HAND DEFORMITY 4 0.0003
636 PULMONARY CONGESTION 4 0.0003
637 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
638 EYE PAIN 17 0.0003
639 CYTOMEGALOVIRUS INFECTION 5 0.0003
640 PREGNANCY 6 0.0003
641 VAGINAL HAEMORRHAGE 13 0.0003
642 PALPITATIONS 35 0.0003
643 QUALITY OF LIFE DECREASED 4 0.0003
644 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
645 JAUNDICE 8 0.0003
646 VOMITING 139 0.0003
647 DRUG LEVEL DECREASED 3 0.0003
648 PRODUCT USE IN UNAPPROVED INDICATION 73 0.0003
649 MOOD ALTERED 8 0.0003
650 EYE MOVEMENT DISORDER 2 0.0003
651 PRODUCT PREPARATION ERROR 6 0.0003
652 SWELLING FACE 19 0.0003
653 SKIN LESION 8 0.0003
654 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
655 EXPOSURE DURING PREGNANCY 18 0.0003
656 DRUG INEFFECTIVE 381 0.0003
657 INJECTION SITE HAEMORRHAGE 23 0.0003
658 UNDERDOSE 21 0.0003
659 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
660 EOSINOPHILIA 5 0.0003
661 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
662 DUODENAL ULCER 2 0.0003
663 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
664 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
665 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
666 ABDOMINAL DISTENSION 29 0.0003
667 DEHYDRATION 37 0.0003
668 DEEP VEIN THROMBOSIS 18 0.0003
669 GAIT DISTURBANCE 53 0.0003
670 DEPRESSION 63 0.0003
671 OEDEMA 15 0.0003
672 CHOLELITHIASIS 9 0.0003
673 ASTHMA 31 0.0003
674 APATHY 4 0.0003
675 GASTROENTERITIS 4 0.0003
676 INJECTION SITE SWELLING 21 0.0003
677 LOSS OF CONSCIOUSNESS 35 0.0003
678 INJECTION SITE NODULE 3 0.0003
679 ACUTE MYOCARDIAL INFARCTION 8 0.0003
680 DENTAL CARIES 3 0.0003
681 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
682 CEREBRAL DISORDER 2 0.0003
683 SYNCOPE 27 0.0003
684 HYPERSENSITIVITY 50 0.0003
685 RESPIRATORY TRACT INFECTION 7 0.0003
686 GLOSSODYNIA 6 0.0003
687 MIDDLE INSOMNIA 5 0.0003
688 DEAFNESS 7 0.0003
689 SNEEZING 6 0.0003
690 NEPHROPATHY TOXIC 3 0.0003
691 FISTULA 3 0.0003
692 DYSPEPSIA 26 0.0003
693 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
694 PULMONARY EMBOLISM 25 0.0003
695 DERMATITIS CONTACT 3 0.0003
696 FEELING JITTERY 5 0.0003
697 DIABETES MELLITUS 20 0.0003
698 ABDOMINAL PAIN 61 0.0003
699 HERNIA 5 0.0003
700 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
701 APNOEA 2 0.0003
702 COUGH 72 0.0003
703 INFUSION RELATED REACTION 17 0.0003
704 BASAL CELL CARCINOMA 4 0.0003
705 NERVOUS SYSTEM DISORDER 8 0.0003
706 SPLENOMEGALY 3 0.0003
707 AFFECTIVE DISORDER 2 0.0003
708 ATAXIA 3 0.0003
709 DRUG ABUSE 21 0.0003
710 PRODUCT PRESCRIBING ERROR 6 0.0003
711 MOOD SWINGS 8 0.0003
712 ABSCESS 4 0.0003
713 OVERDOSE 54 0.0003
714 METABOLIC ACIDOSIS 8 0.0002
715 BLOOD DISORDER 2 0.0002
716 HEPATIC ENZYME INCREASED 17 0.0002
717 BLISTER 14 0.0002
718 INFECTION 36 0.0002
719 DRUG EFFECT INCOMPLETE 9 0.0002
720 CONFUSIONAL STATE 40 0.0002
721 PRESYNCOPE 6 0.0002
722 DYSKINESIA 10 0.0002
723 DYSPNOEA 139 0.0002
724 HYPERTENSION 52 0.0002
725 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
726 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
727 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
728 CARDIOMEGALY 3 0.0002
729 HERPES ZOSTER 14 0.0002
730 ACUTE CORONARY SYNDROME 2 0.0002
731 SLEEP DISORDER 17 0.0002
732 PEMPHIGUS 3 0.0002
733 DYSSTASIA 7 0.0002
734 SECRETION DISCHARGE 3 0.0002
735 COLITIS 9 0.0002
736 ABDOMINAL PAIN LOWER 6 0.0002
737 HEMIPARESIS 4 0.0002
738 BLOOD PRESSURE INCREASED 36 0.0002
739 INJECTION SITE ERYTHEMA 29 0.0002
740 BLOOD POTASSIUM DECREASED 7 0.0002
741 INSOMNIA 62 0.0002
742 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
743 SKIN ULCER 6 0.0002
744 PARANOIA 4 0.0002
745 BLOOD MAGNESIUM DECREASED 2 0.0002
746 TOXICITY TO VARIOUS AGENTS 39 0.0002
747 DIPLOPIA 6 0.0002
748 STOMATITIS 14 0.0002
749 PRODUCTIVE COUGH 11 0.0002
750 RASH ERYTHEMATOUS 11 0.0002
751 SEPTIC SHOCK 10 0.0002
752 ORTHOSTATIC HYPOTENSION 4 0.0002
753 LOCAL SWELLING 4 0.0002
754 INTENTIONAL PRODUCT MISUSE 20 0.0002
755 NEUROTOXICITY 4 0.0002
756 BLOOD CALCIUM INCREASED 2 0.0002
757 ORAL CANDIDIASIS 3 0.0002
758 MELAENA 5 0.0002
759 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
760 ASTHENIA 85 0.0002
761 VISION BLURRED 31 0.0002
762 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
763 CARDIAC DISORDER 21 0.0002
764 PULMONARY OEDEMA 10 0.0002
765 ACUTE KIDNEY INJURY 34 0.0002
766 RASH PRURITIC 12 0.0002
767 OSTEOMYELITIS 4 0.0002
768 PNEUMONITIS 6 0.0002
769 CONDITION AGGRAVATED 67 0.0002
770 PANIC ATTACK 8 0.0002
771 HYPOTHYROIDISM 7 0.0002
772 RASH 95 0.0002
773 ABNORMAL DREAMS 6 0.0002
774 URINARY TRACT INFECTION 37 0.0002
775 SEIZURE 25 0.0002
776 AGRANULOCYTOSIS 4 0.0002
777 WOUND 6 0.0002
778 WITHDRAWAL SYNDROME 9 0.0002
779 APPENDICITIS 2 0.0002
780 ILL-DEFINED DISORDER 13 0.0002
781 BLOOD TEST ABNORMAL 3 0.0002
782 FLANK PAIN 2 0.0002
783 SKIN REACTION 3 0.0002
784 DIALYSIS 3 0.0002
785 FEBRILE NEUTROPENIA 14 0.0002
786 OCULAR HYPERAEMIA 10 0.0002
787 VIRAL INFECTION 7 0.0002
788 BRONCHOSPASM 3 0.0002
789 LIP SWELLING 7 0.0002
790 COMA 10 0.0002
791 DIARRHOEA 135 0.0002
792 SOMNOLENCE 42 0.0002
793 LETHARGY 12 0.0002
794 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
795 POST PROCEDURAL COMPLICATION 4 0.0002
796 DEPRESSED MOOD 11 0.0002
797 AFFECT LABILITY 2 0.0002
798 BRADYCARDIA 11 0.0002
799 HYPERTHYROIDISM 3 0.0002
800 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
801 FEELING ABNORMAL 49 0.0002
802 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
803 OSTEONECROSIS OF JAW 5 0.0002
804 SINUS DISORDER 4 0.0002
805 BLADDER DISORDER 2 0.0002
806 ABORTION SPONTANEOUS 8 0.0002
807 HAEMATOCHEZIA 11 0.0002
808 INJURY 14 0.0002
809 HEPATIC FAILURE 6 0.0002
810 PRODUCT ADMINISTRATION ERROR 4 0.0002
811 OSTEOPENIA 3 0.0002
812 BODY TEMPERATURE INCREASED 4 0.0002
813 OXYGEN SATURATION DECREASED 11 0.0002
814 THYROID DISORDER 3 0.0002
815 DELUSION 3 0.0002
816 HAEMATOMA 5 0.0002
817 CYANOSIS 3 0.0002
818 AGITATION 14 0.0002
819 KNEE ARTHROPLASTY 4 0.0002
820 HALLUCINATION, AUDITORY 3 0.0002
821 EYE SWELLING 7 0.0002
822 EPISTAXIS 14 0.0002
823 DYSARTHRIA 7 0.0002
824 DYSPNOEA EXERTIONAL 7 0.0002
825 WHEEZING 11 0.0002
826 ACNE 14 0.0002
827 BACK DISORDER 3 0.0002
828 BACK INJURY 2 0.0002
829 LUNG DISORDER 9 0.0002
830 HEART RATE INCREASED 18 0.0002
831 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
832 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
833 THROMBOCYTOPENIA 20 0.0002
834 CELLULITIS 9 0.0002
835 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
836 THERAPY NON-RESPONDER 8 0.0002
837 CANDIDA INFECTION 3 0.0002
838 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
839 CHEST DISCOMFORT 18 0.0002
840 MULTI-ORGAN FAILURE 3 0.0002
841 NEEDLE ISSUE 5 0.0002
842 RENAL DISORDER 8 0.0002
843 RASH MACULAR 6 0.0002
844 BLOOD IRON DECREASED 2 0.0002
845 BACTERAEMIA 2 0.0002
846 OFF LABEL USE 147 0.0002
847 POLLAKIURIA 7 0.0002
848 MUSCULAR WEAKNESS 19 0.0002
849 WEIGHT INCREASED 37 0.0002
850 PELVIC PAIN 3 0.0002
851 PRODUCT USE ISSUE 31 0.0002
852 PLEURAL EFFUSION 10 0.0002
853 VERTIGO 10 0.0002
854 LIMB DISCOMFORT 5 0.0002
855 HALLUCINATION 12 0.0002
856 BLOOD SODIUM DECREASED 3 0.0002
857 CARDIOVASCULAR DISORDER 4 0.0002
858 BURNING SENSATION 11 0.0002
859 RASH GENERALISED 4 0.0002
860 WEIGHT DECREASED 43 0.0002
861 HAEMORRHOIDS 3 0.0002
862 CHOKING 3 0.0002
863 PRODUCT DOSE OMISSION 10 0.0002
864 PSORIASIS 20 0.0002
865 BEDRIDDEN 2 0.0002
866 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
867 ADVERSE REACTION 2 0.0002
868 BALANCE DISORDER 13 0.0002
869 SKIN DISORDER 5 0.0001
870 IRRITABILITY 9 0.0001
871 DYSGEUSIA 11 0.0001
872 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
873 ACUTE HEPATIC FAILURE 2 0.0001
874 HAEMOGLOBIN DECREASED 15 0.0001
875 CORONARY ARTERY OCCLUSION 2 0.0001
876 BLOOD GLUCOSE DECREASED 7 0.0001
877 VISUAL IMPAIRMENT 18 0.0001
878 TOOTH LOSS 3 0.0001
879 PULMONARY HYPERTENSION 3 0.0001
880 MEDICATION ERROR 8 0.0001
881 HAEMORRHAGE 15 0.0001
882 APHONIA 2 0.0001
883 RENAL IMPAIRMENT 12 0.0001
884 HALLUCINATION, VISUAL 3 0.0001
885 ERYTHEMA 29 0.0001
886 EATING DISORDER 3 0.0001
887 DRY EYE 7 0.0001
888 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
889 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
890 LIVER FUNCTION TEST ABNORMAL 4 0.0001
891 RESPIRATORY FAILURE 10 0.0001
892 DYSPHONIA 8 0.0001
893 RENAL FAILURE 18 0.0001
894 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
895 PRURITUS 52 0.0001
896 TRANSAMINASES INCREASED 3 0.0001
897 CATARACT 8 0.0001
898 ORAL PAIN 3 0.0001
899 NERVOUSNESS 7 0.0001
900 PNEUMONIA 43 0.0001
901 MEMORY IMPAIRMENT 18 0.0001
902 EMOTIONAL DISORDER 4 0.0001
903 TREATMENT NONCOMPLIANCE 7 0.0001
904 FALL 42 0.0001
905 ANAEMIA 24 0.0001
906 NEUTROPENIA 17 0.0001
907 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
908 STAPHYLOCOCCAL INFECTION 4 0.0001
909 EXPIRED PRODUCT ADMINISTERED 4 0.0001
910 PNEUMONIA ASPIRATION 3 0.0001
911 LEUKOPENIA 6 0.0001
912 AGGRESSION 6 0.0001
913 CARDIO-RESPIRATORY ARREST 5 0.0001
914 TYPE 2 DIABETES MELLITUS 4 0.0001
915 ANGER 4 0.0001
916 AMENORRHOEA 2 0.0001
917 HYPERKALAEMIA 4 0.0001
918 COLD SWEAT 2 0.0001
919 LYMPHADENOPATHY 4 0.0001
920 FEAR 3 0.0001
921 CRYING 4 0.0001
922 CONSTIPATION 24 0.0001
923 ACCIDENTAL OVERDOSE 4 0.0001
924 HYPOKALAEMIA 5 0.0001
925 DIVERTICULITIS 3 0.0001
926 PROCEDURAL PAIN 3 0.0001
927 INTESTINAL OBSTRUCTION 4 0.0001
928 DYSPHAGIA 10 0.0001
929 RED BLOOD CELL COUNT DECREASED 3 0.0001
930 HYPERSOMNIA 3 0.0001
931 DRUG WITHDRAWAL SYNDROME 9 0.0001
932 DISABILITY 2 0.0001
933 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
934 INJECTION SITE PAIN 31 0.0001
935 SEPSIS 11 0.0001
936 DRUG ADMINISTRATION ERROR 3 0.0001
937 ADVERSE EVENT 9 0.0001
938 DISEASE PROGRESSION 11 0.0001
939 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
940 OSTEONECROSIS 3 0.0001
941 EMOTIONAL DISTRESS 11 0.0001
942 FLATULENCE 5 0.0001
943 SURGERY 5 0.0001
944 ARRHYTHMIA 4 0.0001
945 MULTIPLE SCLEROSIS 4 0.0001
946 INTERSTITIAL LUNG DISEASE 4 0.0001
947 CHRONIC KIDNEY DISEASE 6 0.0001
948 ADVERSE DRUG REACTION 7 0.0001
949 ILLNESS 8 0.0001
950 ABNORMAL BEHAVIOUR 3 0.0001
951 INJECTION SITE PRURITUS 5 0.0001
952 MYOCARDIAL INFARCTION 13 0.0001
953 DRUG EFFECT DECREASED 4 0.0001
954 BLOOD BILIRUBIN INCREASED 2 0.0001
955 DEVICE MALFUNCTION 5 0.0001
956 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
957 DRY SKIN 9 0.0001
958 THROAT IRRITATION 3 0.0001
959 INCORRECT DOSE ADMINISTERED 15 0.0001
960 SKIN IRRITATION 3 0.0001
961 COGNITIVE DISORDER 3 0.0001
962 BONE DENSITY DECREASED 2 0.0001
963 CARDIAC FAILURE 5 0.0001
964 ATRIAL FIBRILLATION 6 0.0001
965 SKIN EXFOLIATION 5 0.0001
966 BLOOD GLUCOSE INCREASED 11 0.0001
967 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
968 DRUG DEPENDENCE 9 0.0001
969 SKIN BURNING SENSATION 4 0.0001
970 HYPONATRAEMIA 3 0.0001
971 CEREBROVASCULAR ACCIDENT 9 0.0001
972 EXTRA DOSE ADMINISTERED 2 0.0000
973 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
974 CARDIAC ARREST 4 0.0000
975 DEVICE LEAKAGE 2 0.0000
976 HOSPITALISATION 7 0.0000
977 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
978 UNEVALUABLE EVENT 3 0.0000
979 ECZEMA 2 0.0000
980 THROMBOSIS 3 0.0000
981 PRODUCT QUALITY ISSUE 5 0.0000
982 DEPENDENCE 2 0.0000
983 EYE IRRITATION 2 0.0000
984 NO ADVERSE EVENT 6 0.0000
985 NEUROPATHY PERIPHERAL 3 0.0000
986 COVID-19 5 0.0000
987 DRUG DOSE OMISSION 4 0.0000
988 COMPLETED SUICIDE 2 0.0000
989 DEVICE ISSUE 2 0.0000
990 DEATH 10 0.0000